Systematic review of drug utilization studies & the use of the drug classification system in the WHO-SEARO region

Indian Journal of Medical Research

Volumn 142, Issue AUGUST, 2015, Pages 120-129

  Bachhav, Sagar S ^a,b   Kshirsagar, Nilima A ^a,c  

^a Genetic Research Centre India   (India)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^c NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

Anatomical therapeutic chemical (ATC) classification; ATC DDD; Defined daily dose (DDD); Drug use; Prescription monitoring

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIINFECTIVE AGENT; PRESCRIPTION DRUG;

DRUG CLASSIFICATION; DRUG DATABASE; DRUG USE; DRUG UTILIZATION; HUMAN; METHODOLOGY; PRESCRIPTION; REVIEW; SCIENTIFIC LITERATURE; SOUTHEAST ASIA; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION; CLASSIFICATION; DOSE RESPONSE; INDIA; THAILAND;

ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION; HUMANS; INDIA; PRESCRIPTION DRUGS; THAILAND; WORLD HEALTH ORGANIZATION;

EID: 84940824658     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.164223     Document Type: Review

References (32)

1. Engel A, Siderius P. The consumption of drugs; report on a study, 1966-1967. Copenhagen: World Health Organization, Regional Office for Europe; 1968.
2. Ronning M. Coding and classification in drug statistics-From national to global application. Norwegian J Epidemiol 2001; 11: 37-40.
3. WHO. What is drug utilization research and why is it needed? In: Introduction to drug utilization research. Chapter 1. Geneva: World Health Organization; 2003. p. 8-12. Available from: http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf, accessed on September 30, 2011.
4. ATC/DDD classification: drug utilization data constrains in developing countries. WHO Drug Inf 2002; 16: 233-40. Available from: http://apps.who.int/medicinedocs/pdf/s4951e/s4951e.pdf, accessed on June 28, 2013.
5. Guidelines for ATC classification and DDD assignment 2011. 14th ed. Oslo, Norway: WHO Collaborating Centre for Drug Statistics methodology. Norwegian Institute of Public Health, 2011. Available from: http://www.whocc.no/filearchive/publications/2011guidelines.pdf, accessed on May 30, 2012.
6. PRISMA-Transparent reporting of systematic reviews and meta-analysis. Available from: http://www.prisma-statement.org, accessed on October 2, 2011.
7. The Cochrane Collaboration 2006. Cochran handbook for systematic reviews of interventions 4.2.6, updated September 2006. Available from: http://www.cochrane.org/sites/default/files/uploads/Handbook4.2.6Sep2006.pdf, accessed on October 30, 2011.
8. Viswanathan N, Gandhi IS, Shashindran CH, Adithan C. Drug utilisation study of antimicrobial agents. Indian J Med Res 1981; 74: 772-8.
9. Limpanasithikul W, Wangsaturaka D, Nantawan P, Itthipanichapong C, Thamaree S, Wittayalertpanya S, et al. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2002; 85 (Suppl 1): S336-43.
10. Hadi U, Keuter M, van Asten H, vanden Broek P; Study Group Antimicrobial resistance in Indonesia: Prevalence and Prevention (AMRIN). Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Trop Med Int Health 2008; 13: 888-99.
11. Sharma PR, Barman P. Antimicrobial consumption and impact of “Reserve antibiotic indent form” in an intensive care unit. Indian J Pharmacol 2010; 42: 297-300.
12. Pathak A, Mahadik K, Dhaneria SP, Sharma A, Eriksson B, Lundborg CS, et al. Surveillance of antibiotic consumption using the ‘‘focus of infection’’ approach in 2 hospitals in Ujjain, India. PLoS One 2012; 7: e38641.
13. Jimmy B, Parthasarthi G, Jose J. Drug utilization evaluation of third generation cephalosporins in a tertiary care hospital in South India. Indian JPharm Educ Res 2008; 42: 295-300.
14. Apisarnthanarak A, Yatrasert A, Mundy LM; Thammasat University Antimicrobial Stewardship Team. Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center. Infect Control Hosp Epidemiol 2010; 31: 722-7.
15. Santoso B, Suryawati S, Prawaitasari JE. Small Group intervention vs formal seminar for improving appropriate drug use. Soc SciMed 1996; 42: 1163-8.
16. Chaudhari V, Chaudhari B, Khairnar A. A cross-sectional prescription audit database for anti-anginal drugs with impact of essential drug list and standard treatment guidelines on prescription pattern in Nasik city. Res J Pharm Technol 2011; 4: 1111-4.
17. Seneviratne SL, Gunatilake SB, Adhikari AA, Gunawardhana P, de-Silva HJ. Changing prescribing behaviour: early low dose aspirin in suspected acute myocardial infarction. Int J Cardiol 1998; 67: 237-40.
18. Biswal S, Mishra P, Malhotra S, Puri GD, Pandhi P. Drug utilization pattern in the intensive care unit of a tertiary care hospital. J Clin Pharmacol 2006; 46: 945-51.
19. WHO. WHO policy perspectives on medicines. Promoting rational use of medicines: core components. Geneva: World Health Organization, September 2002. Available from: http://apps.who.int/medicinedocs/pdf/h3011e/h3011e.pdf, accessed on May 30, 2012.
20. WHO. How to investigate drug use in health facilities. Selected drug use indicators- EDM Research Series No. 007. Geneva, World Health Organization, 1993. Available from: http://apps.who.int/medicinedocs/en/d/Js2289e/8.6.html, accessed on June 13, 2012.
21. Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001; 16: 13-20.
22. Hogerzeil HV, Bimo S, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, et al. Field-tests for rational drugs use in twelve developing countries. Lancet 1993; 342: 1408-10.
23. Irwin A, Sharland M. Measuring antibiotic prescribing in hospitalised children in resource-poor countries: a systematic review. JPaediatr Child Health 2013; 49: 185-92.
24. WHO. Drug classification systems. In: Introduction to drug utilization research. Chapter 5. Geneva: World Health Organization; 2003. p. 33-37. Available from: http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf, accessed on September 30, 2011.
25. WHO. The world medicines situation. Geneva: World Health Organization, 2004. Available from: http://apps.who.int/medicinedocs/pdf/s6160e/s6160e.pdf, accessed on June 13, 2012.
26. Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis 2011; 11: 99.
27. Holloway K, Mathai E, Gray A; Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group. Surveillance of community antimicrobial use in resource constrained settings-experience from five pilot projects. Trop Med Int Health 2011; 16: 152-61.
28. Teng L, Xin HW, Blix HS, Tsutani K. Review of the use of defined daily dose concept in drug utilisation research in China. Pharmacoepidemiol Drug Saf 2012; 21: 1118-24.
29. WHO. World malaria report 2012: South-East Asia Region 2012. p. 84-5. Available from: http://who.int/entity/malaria/data/sear12.pdf, accessed on January 30, 2013.
30. WHO. Regional strategy on health information systems. New Delhi: World Health Organization, Regional Office for SouthEast Asia; 2010. Available from: http://www.searo.who.int/LinkFiles/RC_63_a-17-SEA-RC63-26.pdf, accessed on June 13, 2012.
31. Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011; 378: 1139-65.
32. Ross-Degnan D, Laing R, Quick J, Ali HM, Ofori-Adjei D, Salako L, et al. A strategy for promoting improved pharmaceutical use: the International Network for Rational Use of Drugs. Soc Sci Med 1992; 35: 1329-41.